OS Therapies Incorporated (OSTX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

OS Therapies Incorporated (OSTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $84.2M, listed on AMEX, employing roughly 4 people, carrying a beta of -1.34 to the broader market. OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Led by Paul A. Romness, public since 2024-08-01.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for OSTX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →